REFERENCES

1. Todkar SS, Gujarathi VV, et al. Period Prevalence and Sociodemographic Factors of Hypertension in Rural Maharashtra: A Cross Sectional Study. Indian Journal of Community Medicine. 2009; 34 (3):183–187.
2. Parving HH. Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens. 1996 Suppl;14 (2): S89- 93.
3. Toto RD J. Microalbuminuria: definition, detection, and clinical significance. ClinHypertens (Greenwich). 2004; 6(11 Suppl 3): 2-7.
4. Lehmann R, Spinas GA, SchweizRundsch. Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus. Med Prax 1995; 84(44): 1265-71.
5. Asselbergs FW, Diercks GF, Hillege HL, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation. 2004;110(18):2809–2816.
6. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870–878.
7. Toto RD J. Microalbuminuria: definition, detection, and clinical significance. ClinHypertens (Greenwich). 2004; 6(11 Suppl 3): 2-7.
8. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): Resetting the hypertension sails. Hypertension 2003; 41:1178-9.
9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
10. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes.1998;47 (5):793–800.
11. Kubo M, Kiyohara Y, Kato I, et al. Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study. Kidney Int 1999;55(6):2450–2456.
12. Col M, Ocaktan E, Ozdemir O, Yalcin A, Tuncbilek A. Microalbuminuria: prevalence in hypertensives and diabetics. Acta Med Austriaca. 2004;31(1):23–29.
13. Fischbacher CM, Bhopal R, Rutter MK, et al. Microalbuminuria is more frequent in South Asian than in European origin populations: a compara- tive study in Newcastle, UK. Diabet Med. 2003;20 (1):31–36.
14. Tomura S, Kawada K, Saito K, et al. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am J Nephrol. 1999;19(1):13–20.
15. Tripathi SS, Mishra M: Prevalence and Risk Factors of Microalbuminuria in Hypertensive Patients of Tertiary Care Hospital. Int J Life SciScient Res 2017; 3 (5):1382-1386.
16. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887.
17. Freiberg MS, Pencina MJ, D’Agostino RB, Lanier K, Wilson PW, Vasan RS. BMI vs waist circumference for identifying vascular risk. Obesity. 2008;16:463–469.
18. Hasit DL, Vasudha KC. A study of the levels of urinary microalbumin in non-diabetic normotensive obese individuals. Advances in Biological Chemistry 2012;2:171-175.